Radiation Therapy Compliance/Quality Assurance (QA) in 2 Phase 2 Trials of Cetuximab Plus Combined Modality Therapy (CMT) Including Chemotherapy and Radiation Therapy (RT) for Patients With Squamous Cell Carcinoma of the Anal Canal (SCCAC) (AMC045).
Saved in:
| Title: | Radiation Therapy Compliance/Quality Assurance (QA) in 2 Phase 2 Trials of Cetuximab Plus Combined Modality Therapy (CMT) Including Chemotherapy and Radiation Therapy (RT) for Patients With Squamous Cell Carcinoma of the Anal Canal (SCCAC) (AMC045). |
|---|---|
| Authors: | Garg, M.K.1, Zhao, F.2, Lee, J.3, Sparano, J.4, Palefsky, J.5, Henry, D.6, Wachsman, W.7, Rajdev, L.4, Aboulafia, D.8, Mitchell, E.9, Onitilo, A.10, El-Rayes, B.11, Nabbout, N.12, Fitzgerald, T.13, Mitsuyasu, R.14, Benson, A.B.15, Kachnic, L.A.16 |
| Source: | International Journal of Radiation Oncology, Biology, Physics. Oct2016 Supplement, Vol. 96, pS106-S107. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
